Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 106, Issue 6

The saga to monitor and control norovirus: the rise of GII.17 Open Access

Abstract

Norovirus is a major cause of acute gastroenteritis in all age groups, with recent surges of cases in Europe and the USA reinforcing the influence of this virus on human health. Despite its societal impact, no vaccine or antiviral drug is available. The development of these countermeasures has been impaired at least in part by the extreme genetic and antigenic diversity of noroviruses. Here, we reviewed historical norovirus outbreaks, including the pandemics of GII.4 norovirus that were first documented in the mid-1990s, sporadic increases of non-GII.4 norovirus (e.g. GII.17 and GII.2) during the 2010s and, most recently, the ongoing large outbreaks caused by a new cluster of GII.17 noroviruses. This five-decade-long journey of tracking noroviruses in the human population illustrates the importance and challenges of battling this evolving virus.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antigenic diversity , diarrhea , histo-blood group antigen (HBGA) , norovirus and virus evolution
Funding
This study was supported by the:
  • U.S. Food and Drug Administration (Award Z01 BK 04012 LHV)
    • Principle Award Recipient: GabrielI Parra
© Microbiology Society
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.002118
2025-06-06
2025-06-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/106/6/jgv002118.html?itemId=/content/journal/jgv/10.1099/jgv.0.002118&mimeType=html&fmt=ahah

References

  1. Zahorsky J. Hyperemesis hiemis or the winter vomiting disease. Arch Pediatr 1929; 46:391–395
     [Google Scholar]
  2. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 1972; 10:1075–1081 [View Article]
     [Google Scholar]
  3. Thornhill TS, Wyatt RG, Kalica AR, Dolin R, Chanock RM et al. Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. J Infect Dis 1977; 135:20–27 [View Article] [PubMed]
     [Google Scholar]
  4. Dolin R, Reichman RC, Roessner KD, Tralka TS, Schooley RT et al. Detection by immune electron microscopy of the Snow Mountain agent of acute viral gastroenteritis. J Infect Dis 1982; 146:184–189 [View Article] [PubMed]
     [Google Scholar]
  5. Buscho RF, Wyatt RG, Dolin R, Blacklow NR, Dupont HL et al. Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology. Am J Epidemiol 1973; 98:192–198 [View Article]
     [Google Scholar]
  6. Karangwa CK, Parra GI, Bok K, Johnson JA, Levenson EA et al. Sequential gastroenteritis outbreaks in a single year caused by norovirus genotypes GII.2 and GII.6 in an institutional setting. Open Forum Infect Dis 2017; 4:fx236 [View Article]
     [Google Scholar]
  7. Johnson JA, Parra GI, Levenson EA, Green KY. A large outbreak of acute gastroenteritis in Shippensburg, Pennsylvania, 1972 revisited: evidence for common source exposure to a recombinant GII.Pg/GII.3 norovirus. Epidemiol Infect 2017; 145:1591–1596 [View Article]
     [Google Scholar]
  8. Sawyer LA, Murphy JJ, Kaplan JE, Pinsky PF, Chacon D et al. 25- to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission. Am J Epidemiol 1988; 127:1261–1271 [View Article] [PubMed]
     [Google Scholar]
  9. Cubitt WD, Blacklow NR, Herrmann JE, Nowak NA, Nakata S et al. Antigenic relationships between human caliciviruses and Norwalk virus. J Infect Dis 1987; 156:806–814 [View Article] [PubMed]
     [Google Scholar]
  10. Kasuga K, Tokieda M, Ohtawara M, Utagawa E, Yamazaki S. Small round structured virus associated with an outbreak of acute gastroenteritis in Chiba, Japan. Jpn J Med Sci Biol 1990; 43:111–121 [View Article] [PubMed]
     [Google Scholar]
  11. Taniguchi K, Urasawa S, Urasawa T. Virus-like particle, 35 to 40 nm, associated with an institutional outbreak of acute gastroenteritis in adults. J Clin Microbiol 1979; 10:730–736 [View Article] [PubMed]
     [Google Scholar]
  12. Clarke SK, Cook GT, Egglestone SI, Hall TS, Miller DL et al. A virus from epidemic vomiting disease. Br Med J 1972; 3:86–89 [View Article] [PubMed]
     [Google Scholar]
  13. Appleton H, Buckley M, Thom BT, Cotton JL, Henderson S. Virus-like particles in winter vomiting disease. Lancet 1977; 1:409–411 [View Article] [PubMed]
     [Google Scholar]
  14. Wyatt RG, Zapikian AZ. Viral agents associated with acute gastroenteritis in humans. Am J Clin Nutr 1977; 30:1857–1870 [View Article] [PubMed]
     [Google Scholar]
  15. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF et al. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis 1974; 129:709–714 [View Article] [PubMed]
     [Google Scholar]
  16. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 1977; 297:86–89 [View Article] [PubMed]
     [Google Scholar]
  17. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9:548–553 [View Article] [PubMed]
     [Google Scholar]
  18. Rockx BHG, Vennema H, Hoebe CJPA, Duizer E, Koopmans MPG. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 2005; 191:749–754 [View Article] [PubMed]
     [Google Scholar]
  19. Hutson AM, Airaud F, LePendu J, Estes MK, Atmar RL. Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol 2005; 77:116–120 [View Article] [PubMed]
     [Google Scholar]
  20. Marionneau S, Ruvoën N, Le Moullac-Vaidye B, Clement M, Cailleau-Thomas A et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002; 122:1967–1977 [View Article] [PubMed]
     [Google Scholar]
  21. Haga K, Ettayebi K, Tenge VR, Karandikar UC, Lewis MA et al. Genetic manipulation of human intestinal enteroids demonstrates the necessity of a functional FUT2 gene for secretor-dependent human norovirus infection. mBio 2020; 11:e00251-20 [View Article] [PubMed]
     [Google Scholar]
  22. Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology 1993; 195:51–61 [View Article] [PubMed]
     [Google Scholar]
  23. Lambden PR, Caul EO, Ashley CR, Clarke IN. Sequence and genome organization of a human small round-structured (Norwalk-like) virus. Science 1993; 259:516–519 [View Article] [PubMed]
     [Google Scholar]
  24. International Committee on Taxonomy of Viruses Current ICTV Taxonomy Release. https://ictv.global/taxonomy
  25. Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods 2002; 100:107–114 [View Article] [PubMed]
     [Google Scholar]
  26. Katayama K, Shirato-Horikoshi H, Kojima S, Kageyama T, Oka T et al. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology 2002; 299:225–239 [View Article] [PubMed]
     [Google Scholar]
  27. Green SM, Lambden PR, Deng Y, Lowes JA, Lineham S et al. Polymerase chain reaction detection of small round-structured viruses from two related hospital outbreaks of gastroenteritis using inosine-containing primers. J Med Virol 1995; 45:197–202 [View Article] [PubMed]
     [Google Scholar]
  28. Jiang X, Wang J, Graham DY, Estes MK. Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol 1992; 30:2529–2534 [View Article] [PubMed]
     [Google Scholar]
  29. Wang J, Jiang X, Madore HP, Gray J, Desselberger U et al. Sequence diversity of small, round-structured viruses in the Norwalk virus group. J Virol 1994; 68:5982–5990 [View Article] [PubMed]
     [Google Scholar]
  30. Green SM, Dingle KE, Lambden PR, Caul EO, Ashley CR et al. Human enteric Caliciviridae: a new prevalent small round-structured virus group defined by RNA-dependent RNA polymerase and capsid diversity. J Gen Virol 1994; 75 (Pt 8):1883–1888 [View Article] [PubMed]
     [Google Scholar]
  31. Green KY, Belliot G, Taylor JL, Valdesuso J, Lew JF et al. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis 2002; 185:133–146 [View Article] [PubMed]
     [Google Scholar]
  32. Maguire AJ, Green J, Brown DW, Desselberger U, Gray JJ. Molecular epidemiology of outbreaks of gastroenteritis associated with small round-structured viruses in East Anglia, United Kingdom, during the 1996-1997 season. J Clin Microbiol 1999; 37:81–89 [View Article] [PubMed]
     [Google Scholar]
  33. Siebenga JJ, Vennema H, Zheng D-P, Vinjé J, Lee BE et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 2009; 200:802–812 [View Article] [PubMed]
     [Google Scholar]
  34. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004; 363:682–688 [View Article] [PubMed]
     [Google Scholar]
  35. Dingle KE, Norovirus H. Norovirus infection control in oxfordshire communities, mutation in a lordsdale norovirus epidemic strain as a potential indicator of transmission routes. J Clin Microbiol 2004; 42:3950–3957 [View Article]
     [Google Scholar]
  36. Parra GI. Emergence of norovirus strains: a tale of two genes. Virus Evol 2019; 5:vez048 [View Article] [PubMed]
     [Google Scholar]
  37. Debbink K, Donaldson EF, Lindesmith LC, Baric RS. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol 2012; 86:1214–1226 [View Article] [PubMed]
     [Google Scholar]
  38. Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF et al. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 2013; 87:2803–2813 [View Article] [PubMed]
     [Google Scholar]
  39. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng D-P et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008; 5:e31 [View Article] [PubMed]
     [Google Scholar]
  40. Parra GI, Abente EJ, Sandoval-Jaime C, Sosnovtsev SV, Bok K et al. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens. J Virol 2012; 86:7414–7426 [View Article] [PubMed]
     [Google Scholar]
  41. Tohma K, Lepore CJ, Gao Y, Ford-Siltz LA, Parra GI. Population genomics of GII.4 noroviruses reveal complex diversification and new antigenic sites involved in the emergence of pandemic strains. mBio 2019; 10:e02202-19 [View Article] [PubMed]
     [Google Scholar]
  42. Kendra JA, Tohma K, Ford-Siltz LA, Lepore CJ, Parra GI. Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses. Proc Natl Acad Sci USA 2021; 118:11 [View Article] [PubMed]
     [Google Scholar]
  43. Lindesmith LC, Boshier FAT, Brewer-Jensen PD, Roy S, Costantini V et al. Immune imprinting drives human norovirus potential for global spread. mBio 2022; 13:e0186122 [View Article] [PubMed]
     [Google Scholar]
  44. Tohma K, Ford-Siltz LA, Kendra JA, Parra GI. Dynamic immunodominance hierarchy of neutralizing antibody responses to evolving GII.4 noroviruses. Cell Rep 2022; 39:110689 [View Article] [PubMed]
     [Google Scholar]
  45. Bull RA, Hansman GS, Clancy LE, Tanaka MM, Rawlinson WD et al. Norovirus recombination in ORF1/ORF2 overlap. Emerg Infect Dis 2005; 11:1079–1085 [View Article] [PubMed]
     [Google Scholar]
  46. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV et al. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 2009; 83:11890–11901 [View Article] [PubMed]
     [Google Scholar]
  47. Mori K, Chu P-Y, Motomura K, Somura Y, Nagano M et al. Genomic analysis of the evolutionary lineage of Norovirus GII.4 from archival specimens during 1975-1987 in Tokyo. J Med Virol 2017; 89:363–367 [View Article] [PubMed]
     [Google Scholar]
  48. Tohma K, Lepore CJ, Martinez M, Degiuseppe JI, Khamrin P et al. Genome-wide analyses of human noroviruses provide insights on evolutionary dynamics and evidence of coexisting viral populations evolving under recombination constraints. PLoS Pathog 2021; 17:e1009744 [View Article] [PubMed]
     [Google Scholar]
  49. Eden J-S, Tanaka MM, Boni MF, Rawlinson WD, White PA. Recombination within the pandemic norovirus GII.4 lineage. J Virol 2013; 87:6270–6282 [View Article] [PubMed]
     [Google Scholar]
  50. Cannon JL, Barclay L, Collins NR, Wikswo ME, Castro CJ et al. Genetic and epidemiologic trends of norovirus outbreaks in the United States from 2013 to 2016 demonstrated emergence of novel GII.4 recombinant viruses. J Clin Microbiol 2017; 55:2208–2221 [View Article] [PubMed]
     [Google Scholar]
  51. Kendra JA, Tohma K, Parra GI. Global and regional circulation trends of norovirus genotypes and recombinants, 1995-2019: a comprehensive review of sequences from public databases. Rev Med Virol 2022; 32:e2354 [View Article] [PubMed]
     [Google Scholar]
  52. van Beek J, de Graaf M, Al-Hello H, Allen DJ, Ambert-Balay K et al. Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network. Lancet Infect Dis 2018; 18:545–553 [View Article] [PubMed]
     [Google Scholar]
  53. Iritani N, Kaida A, Abe N, Sekiguchi J-I, Kubo H et al. Increase of GII.2 norovirus infections during the 2009-2010 season in Osaka City, Japan. J Med Virol 2012; 84:517–525 [View Article] [PubMed]
     [Google Scholar]
  54. Sakon N, Yamazaki K, Nakata K, Kanbayashi D, Yoda T et al. Impact of genotype-specific herd immunity on the circulatory dynamism of norovirus: a 10-year longitudinal study of viral acute gastroenteritis. J Infect Dis 2015; 211:879–888 [View Article] [PubMed]
     [Google Scholar]
  55. Kwok K, Niendorf S, Lee N, Hung T-N, Chan L-Y et al. Increased detection of emergent recombinant norovirus GII.P16-GII.2 strains in young adults, Hong Kong, China, 2016–2017. Emerg Infect Dis 2017; 23:1852–1855 [View Article] [PubMed]
     [Google Scholar]
  56. Tohma K, Lepore CJ, Ford-Siltz LA, Parra GI. Phylogenetic analyses suggest that factors other than the capsid protein play a role in the epidemic potential of GII.2 norovirus. mSphere 2017; 2:e00187-17 [View Article] [PubMed]
     [Google Scholar]
  57. Niendorf S, Jacobsen S, Faber M, Eis-Hübinger AM, Hofmann J et al. Steep rise in norovirus cases and emergence of a new recombinant strain GII.P16-GII.2, Germany, winter 2016. Euro Surveill 2017; 22: [View Article]
     [Google Scholar]
  58. Chan MCW, Lee N, Hung T-N, Kwok K, Cheung K et al. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun 2015; 6:10061 [View Article] [PubMed]
     [Google Scholar]
  59. Lu J, Fang L, Zheng H, Lao J, Yang F et al. The evolution and transmission of epidemic GII.17 noroviruses. J Infect Dis 2016; 214:556–564 [View Article] [PubMed]
     [Google Scholar]
  60. Matsushima Y, Ishikawa M, Shimizu T, Komane A, Kasuo S et al. Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill 2015; 20:26 [View Article] [PubMed]
     [Google Scholar]
  61. Parra GI, Green KY. Genome of emerging norovirus GII.17, United States, 2014. Emerg Infect Dis 2015; 21:1477–1479 [View Article] [PubMed]
     [Google Scholar]
  62. Parra GI, Squires RB, Karangwa CK, Johnson JA, Lepore CJ et al. Static and evolving norovirus genotypes: implications for epidemiology and immunity. PLoS Pathog 2017; 13:e1006136 [View Article] [PubMed]
     [Google Scholar]
  63. Lindesmith LC, Kocher JF, Donaldson EF, Debbink K, Mallory ML et al. Emergence of novel human norovirus GII.17 strains correlates with changes in blockade antibody epitopes. J Infect Dis 2017; 216:1227–1234 [View Article] [PubMed]
     [Google Scholar]
  64. Yee EL, Palacio H, Atmar RL, Shah U, Kilborn C et al. Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis 2007; 44:1032–1039 [View Article] [PubMed]
     [Google Scholar]
  65. Mitui MT, Bozdayi G, Ahmed S, Matsumoto T, Nishizono A et al. Detection and molecular characterization of diarrhea causing viruses in single and mixed infections in children: a comparative study between Bangladesh and Turkey. J Med Virol 2014; 86:1159–1168 [View Article] [PubMed]
     [Google Scholar]
  66. Kageyama T, Shinohara M, Uchida K, Fukushi S, Hoshino FB et al. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to Norovirus in Japan. J Clin Microbiol 2004; 42:2988–2995 [View Article] [PubMed]
     [Google Scholar]
  67. Mori K, Motomura K, Somura Y, Kimoto K, Akiba T et al. Comparison of genetic characteristics in the evolution of Norovirus GII.4 and GII.17. J Med Virol 2017; 89:1480–1484 [View Article] [PubMed]
     [Google Scholar]
  68. Chan MCW, Hu Y, Chen H, Podkolzin AT, Zaytseva EV et al. Global spread of norovirus GII.17 Kawasaki 308, 2014–2016. Emerg Infect Dis 2017; 23:1359–1354 [View Article] [PubMed]
     [Google Scholar]
  69. Strother CA, Brewer-Jensen PD, Becker-Dreps S, Zepeda O, May S et al. Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters. Front Immunol 2023; 14:1229724 [View Article] [PubMed]
     [Google Scholar]
  70. Yi Y, Wang X, Wang S, Xiong P, Liu Q et al. Identification of a blockade epitope of human norovirus GII.17. Emerg Microbes Infect 2021; 10:954–963 [View Article] [PubMed]
     [Google Scholar]
  71. Zhang X-F, Huang Q, Long Y, Jiang X, Zhang T et al. An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility. Sci Rep 2015; 5:17687 [View Article] [PubMed]
     [Google Scholar]
  72. Estienney M, Tarris G, Abou-Hamad N, Rouleau A, Boireau W et al. Epidemiological impact of GII.17 human noroviruses associated with attachment to enterocytes. Front Microbiol 2022; 13:858245 [View Article] [PubMed]
     [Google Scholar]
  73. Jin M, Zhou Y-K, Xie H-P, Fu J-G, He Y-Q et al. Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China. J Gen Virol 2016; 97:2620–2632 [View Article] [PubMed]
     [Google Scholar]
  74. de Graaf M, van Beek J, Vennema H, Podkolzin AT, Hewitt J et al. Emergence of a novel GII.17 norovirus – End of the GII.4 era?. Euro Surveill 2015; 20:26 [View Article] [PubMed]
     [Google Scholar]
  75. Cannon JL, Bonifacio J, Bucardo F, Buesa J, Bruggink L et al. Global trends in norovirus genotype distribution among children with acute gastroenteritis. Emerg Infect Dis 2021; 27:1438–1445 [View Article] [PubMed]
     [Google Scholar]
  76. Parra GI, Tohma K, Ford-Siltz LA, Eguino P, Kendra JA et al. Minimal antigenic evolution after a decade of norovirus GII.4 Sydney_2012 circulation in humans. J Virol 2023; 97:e0171622 [View Article] [PubMed]
     [Google Scholar]
  77. Tohma K, Landivar M, Ford-Siltz LA, Pilewski KA, Kendra JA et al. Antigenic characterization of novel human norovirus GII.4 variants San Francisco 2017 and Hong Kong 2019. Emerg Infect Dis 2024; 30:1026–1029 [View Article] [PubMed]
     [Google Scholar]
  78. Chan MC-W, Roy S, Bonifacio J, Zhang L-Y, Chhabra P et al. Detection of norovirus variant GII.4 Hong Kong in Asia and Europe, 2017–2019. Emerg Infect Dis 2021; 27:289–293 [View Article] [PubMed]
     [Google Scholar]
  79. Chhabra P, Tully DC, Mans J, Niendorf S, Barclay L et al. Emergence of novel norovirus GII.4 variant. Emerg Infect Dis 2024; 30:163–167 [View Article] [PubMed]
     [Google Scholar]
  80. Chuchaona W, Chansaenroj J, Puenpa J, Khongwichit S, Korkong S et al. Human norovirus GII.4 Hong Kong variant shares common ancestry with GII.4 Osaka and emerged in Thailand in 2016. PLoS One 2021; 16:e0256572 [View Article] [PubMed]
     [Google Scholar]
  81. Chhabra P, Wong S, Niendorf S, Lederer I, Vennema H et al. Increased circulation of GII.17 noroviruses, six European countries and the United States, 2023 to 2024. Euro Surveill 2024; 29:39 [View Article] [PubMed]
     [Google Scholar]
  82. Epifanova NV, Oparina SV, Morozova OV, Sashina TA, Alekseeva AE et al. Re-emergence and spread of norovirus genotype GII.17 variant C in 2021–2023 (Preprint). [View Article]
  83. Dinu S, Oprea M, Iordache R-I, Rusu L-C, Usein C-R. Genome characterisation of norovirus GII.P17-GII.17 detected during a large gastroenteritis outbreak in Romania in 2021. Arch Virol 2023; 168:116 [View Article]
     [Google Scholar]
  84. Gomes KA, Degiuseppe JI, Morón PM, Rivero KA, Barrios Matthieur C et al. Multi-province outbreak of acute gastroenteritis linked to potential novel lineage of GII.17 norovirus in Argentina in 2024. Viruses 2025; 17:223 [View Article] [PubMed]
     [Google Scholar]
  85. Infectious agents surveillance report, in monthly report of gastrointestinal pathogens. Japan: National Institute of Infectious Diseases; 2025
  86. Nelson MI, Mahfuz M, Chhabra P, Haque R, Seidman JC et al. Genetic diversity of noroviruses circulating in a pediatric cohort in bangladesh. J Infect Dis 2018; 218:1937–1942 [View Article] [PubMed]
     [Google Scholar]
  87. Saito M, Goel-Apaza S, Espetia S, Velasquez D, Cabrera L et al. Multiple norovirus infections in a birth cohort in a peruvian periurban community. Clin Infect Dis 2014; 58:483–491 [View Article] [PubMed]
     [Google Scholar]
  88. Chhabra P, Rouhani S, Browne H, Peñataro Yori P, Siguas Salas M et al. Homotypic and heterotypic protection and risk of reinfection following natural norovirus infection in a highly endemic setting. Clin Infect Dis 2021; 72:222–229 [View Article] [PubMed]
     [Google Scholar]
  89. Lopman BA, Trivedi T, Vicuña Y, Costantini V, Collins N et al. Norovirus infection and disease in an Ecuadorian birth cohort: association of certain norovirus genotypes with host FUT2 secretor status. J Infect Dis 2015; 211:1813–1821 [View Article] [PubMed]
     [Google Scholar]
  90. Simmons K, Gambhir M, Leon J, Lopman B. Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis 2013; 19:1260–1267 [View Article] [PubMed]
     [Google Scholar]
  91. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J et al. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 2012; 8:e1002705 [View Article] [PubMed]
     [Google Scholar]
  92. Arias A, Thorne L, Ghurburrun E, Bailey D, Goodfellow I. Norovirus polymerase fidelity contributes to viral transmission in vivo. mSphere 2016; 1:e00279-16 [View Article] [PubMed]
     [Google Scholar]
  93. Bull RA, Eden J-S, Rawlinson WD, White PA. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog 2010; 6:e1000831 [View Article] [PubMed]
     [Google Scholar]
  94. Bartsch SM, Lopman BA, Ozawa S, Hall AJ, Lee BY. Global economic burden of norovirus gastroenteritis. PLoS One 2016; 11:e0151219 [View Article] [PubMed]
     [Google Scholar]
  95. Pires SM, Fischer-Walker CL, Lanata CF, Devleesschauwer B, Hall AJ et al. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. PLoS One 2015; 10:e0142927 [View Article] [PubMed]
     [Google Scholar]
  96. Ford-Siltz LA, Wales S, Tohma K, Gao Y, Parra GI. Genotype-specific neutralization of norovirus is mediated by antibodies against the protruding domain of the major capsid protein. J Infect Dis 2022; 225:1205–1214 [View Article] [PubMed]
     [Google Scholar]
  97. Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 2016; 353:1387–1393 [View Article] [PubMed]
     [Google Scholar]
  98. Flitter BA, Greco SN, Lester CA, Neuhaus ED, Tedjakusuma SN et al. An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial. Sci Transl Med 2025; 17:eads0556 [View Article] [PubMed]
     [Google Scholar]
  99. López P, López-Medina E, Sáez-Llorens X, deAntonio R, Masuda T et al. Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: a phase 2 randomized, double-blind trial. Hum Vaccin Immunother 2023; 19:2204787 [View Article] [PubMed]
     [Google Scholar]
  100. Sáez-Llorens X, deAntonio R, López-Medina E, López P, Masuda T et al. Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: a phase 2, randomized, double-blind trial. Hum Vaccin Immunother 2025; 21:2450878 [View Article] [PubMed]
     [Google Scholar]
  101. Rimkute I, Chaimongkol N, Woods KD, Nagata BM, Darko S et al. A non-human primate model for human norovirus infection. Nat Microbiol 2024; 9:776–786 [View Article]
     [Google Scholar]
  102. Sherwood J, Mendelman PM, Lloyd E, Liu M, Boslego J et al. Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults. Vaccine 2020; 38:6442–6449 [View Article]
     [Google Scholar]
  103. ModernaTX, Inc A study to investigate the safety and efficacy of mRNA-1403 in participants ≥18 years of age for the prevention of acute gastroenteritis (Nova 301). https://clinicaltrials.gov/study/NCT06592794 accessed 1 May 2025
     [Google Scholar]
  104. Alvarado G, Salmen W, Ettayebi K, Hu L, Sankaran B et al. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun 2021; 12:4320 [View Article] [PubMed]
     [Google Scholar]
  105. Ford-Siltz LA, Tohma K, Alvarado GS, Kendra JA, Pilewski KA et al. Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein. Front Immunol 2022; 13:1040836 [View Article] [PubMed]
     [Google Scholar]
  106. Lindesmith LC, McDaniel JR, Changela A, Verardi R, Kerr SA et al. Sera antibody repertoire analyses reveal mechanisms of broad and pandemic strain neutralizing responses after human norovirus vaccination. Immunity 2019; 50:1530–1541 [View Article] [PubMed]
     [Google Scholar]
  107. Park J, Lindesmith LC, Olia AS, Costantini VP, Brewer-Jensen PD et al. Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus. Sci Transl Med 2025; 17:eads8214 [View Article] [PubMed]
     [Google Scholar]
  108. Pilewski KA, Ford-Siltz LA, Tohma K, Kendra JA, Landivar M et al. Analysis of archival sera from norovirus-infected individuals demonstrates that cross-blocking of emerging viruses is genotype-specific. J Infect Dis 2024; 230:982–994 [View Article] [PubMed]
     [Google Scholar]
  109. Atmar RL, Ettayebi K, Ramani S, Neill FH, Lindesmith L et al. A bivalent human norovirus vaccine induces homotypic and heterotypic neutralizing antibodies. J Infect Dis 2024; 229:1402–1407 [View Article] [PubMed]
     [Google Scholar]
  110. Kroneman A, Vennema H, Deforche K, v d Avoort H, Peñaranda S et al. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol 2011; 51:121–125 [View Article] [PubMed]
     [Google Scholar]
  111. Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol 2021; 38:3022–3027 [View Article] [PubMed]
     [Google Scholar]
  112. Steven W. Racmacs: antigenic cartography macros (R package version 1.2.9); 2024 https://github.com/acorg/Racmacs
/content/journal/jgv/10.1099/jgv.0.002118
Loading
The saga to monitor and control norovirus: the rise of GII.17
J. Gen. Virol. 106, 002118 (2025); https://doi.org/10.1099/jgv.0.002118
/content/journal/jgv/10.1099/jgv.0.002118
/content/journal/jgv/10.1099/jgv.0.002118
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error